Recruiting
Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
NCT06744647
- Conditions
- AMR, Antibody-mediated Rejection, Biopsy-proven Histologic Scores, +1 more
- Locations
-
- Research Site Birmingham, Alabama, United States
- Research Site Scottsdale, Arizona, United States
- Research Site Los Angeles, California, United States
- Research Site Orange, California, United States